On August 14, 2023, our company successfully passed the CNAS re-evaluation and on-site assessment for scope expansion.

Image Name

2023.08.14

From August 11 to 13, 2023, a five-member expert team from the China National Accreditation Service for Conformity Assessment (CNAS) conducted a two-day on-site review of our company’s laboratory, including both the re-evaluation and expansion of testing scopes. After a rigorous and meticulous assessment, our company successfully passed the review, marking another milestone as we once again receive national-level recognition for our advanced testing capabilities and robust quality management system.

During the review period, the expert panel conducted a comprehensive audit of our company’s management system, technical capabilities, equipment and facilities, as well as personnel qualifications, using methods such as document review, on-site experiments, and staff interviews, all in accordance with relevant CNAS guidelines and requirements. Meanwhile, the panel paid particular attention to the newly proposed testing items in this expansion application, thoroughly verifying that our company indeed possesses the necessary technical expertise and adequate supporting resources.

At the final meeting, the evaluation panel highly praised our company's quality management level and testing capabilities, unanimously concluding that our system is operating effectively and that our technical competence meets the CNAS accreditation requirements. They agreed to recommend us for successful re-evaluation and expansion of scope.

The successful completion of this review not only affirms our company’s longstanding commitment to high standards and rigorous requirements, but also lays a solid foundation for us to further enhance our testing service capabilities and expand our business scope. Moving forward, we will continue to uphold our quality principles—“scientific, impartial, accurate, and efficient”—to deliver even better, more professional testing services to our clients, thereby contributing to the industry’s high-quality development.

West Mountain

Previous article

On March 1, 2024, experts from the Suzhou Municipal Bureau of Agriculture and Rural Affairs visited for an inspection. Our company successfully passed the qualification review for Jiangsu Province's certification as a quarantine and testing laboratory specializing in dogs and cats at their place of origin.

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

Next article

Previous article

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

Next article

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.